查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1905115

日本药物递送市场报告（按给药途径、应用、最终用户和地区划分，2026-2034年）

Japan Pharmaceutical Drug Delivery Market Report by Route of Administration, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本药物递送市场规模达693亿美元。展望未来， IMARC Group预计到2034年，该市场规模将达到1,021亿美元，2026年至2034年间的复合年增长率（CAGR）为4.40%。市场成长的主要驱动力包括：领先企业日益重视个人化医疗，推动药物递送创新，以及奈米技术的许多进步。

本报告解答的关键问题：

  • 日本药物输送市场目前表现如何？未来几年又将如何发展？
  • 新冠疫情对日本药品输送市场产生了哪些影响？
  • 日本药品给药市场依给药途径分類的组成是怎样的？
  • 日本药物输送市场按应用领域分類的组成是怎样的？
  • 日本药品输送市场依最终用户分類的组成是怎样的？
  • 日本药品输送市场价值链的各个阶段有哪些？
  • 日本药品输送的关键驱动因素和挑战是什么？
  • 日本药物输送市场的结构是怎么样的？主要参与者有哪些？
  • 日本药物输送市场的竞争程度如何？

目录

第一章：序言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 数据来源
  • 市场估算
  • 预测方法

第三章：执行概要

第四章：日本药物输送市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本药物输送市场概况

  • 历史及当前市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本药品给药市场－依给药途径划分

  • 口服给药
  • 注射给药
  • 局部给药
  • 眼部药物传递
  • 肺部药物输送
  • 植入式药物输送
  • 经黏膜给药
  • 鼻腔给药

第七章：日本药物输送市场－依应用领域划分

  • 传染病
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 呼吸系统疾病
  • 中枢神经系统疾病
  • 自体免疫疾病
  • 其他的

第八章：日本药物输送市场－以最终用户划分

  • 医院
  • 门诊手术中心
  • 家庭护理机构
  • 诊断中心
  • 其他的

第九章：日本药物输送市场－依地区划分

  • 关东地区
  • 关西/近畿地区
  • 中部/中部地区
  • 九州·冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本药物输送市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争格局分析
  • 公司评估象限

第十一章：关键参与者简介

第十二章：日本药物输送市场－产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章：附录

简介目录
Product Code: SR112026A19555

Japan pharmaceutical drug delivery market size reached USD 69.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 102.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.40% during 2026-2034. The rising emphasis of leading players on personalized medicine fostering drug delivery innovations and numerous advancements in nanotechnology are primarily driving the market growth.

Pharmaceutical drug delivery is the systematic and controlled administration of medicines to patients with the goal of optimizing the therapeutic results. This involves the utilization of various methods and technologies to ensure precise dosage, improved absorption by the body, and the targeted delivery of pharmaceutical compounds to specific locations within the body. The field of drug delivery is focused on improving the effectiveness, safety, and convenience of treatments while minimizing potential side effects. It encompasses a wide array of approaches, including oral, injectable, transdermal, inhalation, and implantable methods. Currently, pharmaceutical drug delivery is gaining significant traction in reshaping patient care on a global scale by maximizing the advantages of medications and facilitating more personalized and efficient therapeutic solutions.

Japan Pharmaceutical Drug Delivery Market Trends:

The pharmaceutical drug delivery market in Japan is experiencing significant growth driven by several compelling factors. Notably, the rising emphasis on personalized medicine and targeted therapies is a key driver, aligning treatment approaches more closely with individual patient needs. Continuous advancements in drug formulation and delivery technologies are also playing a pivotal role in catalyzing market expansion. Researchers in Japan are consistently exploring innovative strategies, including nanotechnology, liposomes, and microparticles, to enhance drug stability, bioavailability, and controlled release. These innovations enable the development of novel drug delivery systems capable of addressing challenges associated with traditional formulations, such as poor solubility, rapid metabolism, or short half-life, thus driving market growth. Moreover, the increasing prevalence of chronic diseases like diabetes, cardiovascular disorders, and cancer is fueling the demand for advanced drug delivery systems in Japan. These conditions often require long-term treatment involving multiple medications, and optimized drug delivery methods can significantly improve therapeutic outcomes and enhance the quality of life for patients. Factors such as rapid urbanization, ongoing enhancements in the healthcare sector, and extensive research and development (R&D) efforts by industry leaders are also contributing positively to the pharmaceutical drug delivery market in Japan. Collectively, these elements are expected to shape a favorable outlook for market growth in the country over the forecasted period.

Japan Pharmaceutical Drug Delivery Market Segmentation:

Route of Administration Insights:

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery
  • Nasal Drug Delivery

Application Insights:

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Others

End User Insights:

  • Hospitals
  • Ambulatory Surgery Centers
  • Home Care Settings
  • Diagnostic Centers
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan pharmaceutical drug delivery market?
  • What is the breakup of the Japan pharmaceutical drug delivery market on the basis of route of administration?
  • What is the breakup of the Japan pharmaceutical drug delivery market on the basis of application?
  • What is the breakup of the Japan pharmaceutical drug delivery market on the basis of end user?
  • What are the various stages in the value chain of the Japan pharmaceutical drug delivery market?
  • What are the key driving factors and challenges in the Japan pharmaceutical drug delivery?
  • What is the structure of the Japan pharmaceutical drug delivery market and who are the key players?
  • What is the degree of competition in the Japan pharmaceutical drug delivery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmaceutical Drug Delivery Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Pharmaceutical Drug Delivery Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Pharmaceutical Drug Delivery Market - Breakup by Route of Administration

  • 6.1 Oral Drug Delivery
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Injectable Drug Delivery
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Topical Drug Delivery
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Ocular Drug Delivery
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Pulmonary Drug Delivery
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Implantable Drug Delivery
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Transmucosal Drug Delivery
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2020-2025)
    • 6.7.3 Market Forecast (2026-2034)
  • 6.8 Nasal Drug Delivery
    • 6.8.1 Overview
    • 6.8.2 Historical and Current Market Trends (2020-2025)
    • 6.8.3 Market Forecast (2026-2034)

7 Japan Pharmaceutical Drug Delivery Market - Breakup by Application

  • 7.1 Infectious Diseases
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Cancer
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Diabetes
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Respiratory Diseases
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Central Nervous System Disorders
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Autoimmune Diseases
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2020-2025)
    • 7.7.3 Market Forecast (2026-2034)
  • 7.8 Others
    • 7.8.1 Historical and Current Market Trends (2020-2025)
    • 7.8.2 Market Forecast (2026-2034)

8 Japan Pharmaceutical Drug Delivery Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Home Care Settings
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Diagnostic Centers
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2020-2025)
    • 8.5.2 Market Forecast (2026-2034)

9 Japan Pharmaceutical Drug Delivery Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Route of Administration
    • 9.1.4 Market Breakup by Application
    • 9.1.5 Market Breakup by End User
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Route of Administration
    • 9.2.4 Market Breakup by Application
    • 9.2.5 Market Breakup by End User
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Route of Administration
    • 9.3.4 Market Breakup by Application
    • 9.3.5 Market Breakup by End User
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Route of Administration
    • 9.4.4 Market Breakup by Application
    • 9.4.5 Market Breakup by End User
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Route of Administration
    • 9.5.4 Market Breakup by Application
    • 9.5.5 Market Breakup by End User
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Route of Administration
    • 9.6.4 Market Breakup by Application
    • 9.6.5 Market Breakup by End User
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Route of Administration
    • 9.7.4 Market Breakup by Application
    • 9.7.5 Market Breakup by End User
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Route of Administration
    • 9.8.4 Market Breakup by Application
    • 9.8.5 Market Breakup by End User
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Pharmaceutical Drug Delivery Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Pharmaceutical Drug Delivery Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix